russ2000_2_0157|CNST|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
russ2000_2_0157|CNST|1|Constellation Pharmaceuticals Inc Total Current Assets (Quarterly) (USD)|Constellation Pharmaceuticals Inc Cash and Short Term Investments (Quarterly) (USD)|Constellation Pharmaceuticals Inc Inventories (Quarterly) (USD)|Constellation Pharmaceuticals Inc Net PP&E (Quarterly) (USD)|Constellation Pharmaceuticals Inc Goodwill and Intangibles (Quarterly) (USD)|Constellation Pharmaceuticals Inc Total Liabilities (Quarterly) (USD)|Constellation Pharmaceuticals Inc Total Current Liabilities (Quarterly) (USD)|Constellation Pharmaceuticals Inc Total Long Term Liabilities (Quarterly) (USD)|Constellation Pharmaceuticals Inc Total Deposits (Quarterly) (USD)|Constellation Pharmaceuticals Inc Book Value (Quarterly) (USD)|Constellation Pharmaceuticals Inc Retained Earnings (Quarterly) (USD)|Constellation Pharmaceuticals Inc Treasury Stock (Quarterly) (USD)|Constellation Pharmaceuticals Inc EV to Revenues|Constellation Pharmaceuticals Inc EV to Earnings|Constellation Pharmaceuticals Inc EV to Free Cash Flow|Constellation Pharmaceuticals Inc EV to Assets (Quarterly)|Constellation Pharmaceuticals Inc PS Ratio|Constellation Pharmaceuticals Inc PE Ratio|Constellation Pharmaceuticals Inc Price to Book Value|Constellation Pharmaceuticals Inc PEG Ratio|Constellation Pharmaceuticals Inc Debt to Equity Ratio|Constellation Pharmaceuticals Inc Dividend Yield|Constellation Pharmaceuticals Inc Shareholder Yield (TTM)|Constellation Pharmaceuticals Inc Percent of Shares Outstanding Short|Constellation Pharmaceuticals Inc Total Receivables (Quarterly) (USD)|Constellation Pharmaceuticals Inc Total Payables (Quarterly) (USD)|Constellation Pharmaceuticals Inc Total Capital Stock (Quarterly) (USD)|Constellation Pharmaceuticals Inc Return on Invested Capital|Constellation Pharmaceuticals Inc Quality Ratio Score|Constellation Pharmaceuticals Inc Momentum Score|Constellation Pharmaceuticals Inc Beta (1Y)|Constellation Pharmaceuticals Inc Sustainable Growth Rate (TTM)|Constellation Pharmaceuticals Inc Institutional Investor Ownership Percentage|Constellation Pharmaceuticals Inc Average Diluted Shares Outstanding (Quarterly)|Constellation Pharmaceuticals Inc Total Employees (Annual)|Constellation Pharmaceuticals Inc EPS Diluted (Quarterly) (USD)|Constellation Pharmaceuticals Inc Shares Outstanding|Constellation Pharmaceuticals Inc Repurchase of Capital Stock (Quarterly) (USD)|Constellation Pharmaceuticals Inc Ordinary Shares Number (Quarterly)|Constellation Pharmaceuticals Inc Payout Ratio|Constellation Pharmaceuticals Inc Quick Ratio (Quarterly)|Constellation Pharmaceuticals Inc Normalized Diluted EPS (Quarterly) (USD)|Constellation Pharmaceuticals Inc Stock Buybacks (Quarterly) (USD)|Constellation Pharmaceuticals Inc Effective Tax Rate (TTM)|Constellation Pharmaceuticals Inc Return on Equity|Constellation Pharmaceuticals Inc Net Income (TTM) (USD)|Constellation Pharmaceuticals Inc Revenue (TTM) (USD)|Constellation Pharmaceuticals Inc Dividend Per Share (Quarterly) (USD)|Constellation Pharmaceuticals Inc Revenue (Quarterly) (USD)|Constellation Pharmaceuticals Inc Gross Profit (Quarterly) (USD)|Constellation Pharmaceuticals Inc SG&A Expense (Quarterly) (USD)|Constellation Pharmaceuticals Inc Pre-Tax Income (Quarterly) (USD)|Constellation Pharmaceuticals Inc Net Income (Quarterly) (USD)|Constellation Pharmaceuticals Inc Net Interest Income (Quarterly) (USD)|Constellation Pharmaceuticals Inc Price (USD)|Constellation Pharmaceuticals Inc Total Return Price (USD)|Constellation Pharmaceuticals Inc Enterprise Value (USD)|Constellation Pharmaceuticals Inc 30-Day Average Daily Volume|Constellation Pharmaceuticals Inc 1 Year Price Returns (Daily)||
russ2000_2_0157|CNST|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
russ2000_2_0157|CNST|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
russ2000_2_0157|CNST|5|91.2|91.2|0|91.2|0|91.2|91.2|91.2|0|91.2|91.2|0|0|0|1.44755244755|0|0|0|1.44807692308|0|0|1.44755244755|0|15.2307692308|0|91.2|91.2|0|0|30.4615384615|30.5|0|0|91.3076923077|274.5|91.3076923077|31.375|0|91.2|0|0|91.3076923077|91.2727272727|0|0|91.2|0|0|0|0|91.3076923077|91.3076923077|91.3076923077|91.3076923077|1.44755244755|1.44755244755|1.44755244755|1.44935543278|1.44236760125||
russ2000_2_0157|CNST|6|10|10|0|10|0|10|10|10|0|10|10|0|0|0|572|0|0|0|520|0|0|572|0|52|0|10|10|0|0|13|14|0|0|13|2|13|24|0|10|0|0|13|11|0|0|10|0|0|0|0|13|13|13|13|572|572|572|543|321||
russ2000_2_0157|CNST|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
russ2000_2_0157|CNST|201703||||||||||||||||||||||||||||||||||1.1992||-8.2291||||||-4.7291|||||||||1.165|-5.671|-5.671|-0.264|||||||
russ2000_2_0157|CNST|201706||||||||||||||||||||||||||||||||||1.1992||-10.273||||||-6.6646|||||||||1.49|-7.992|-7.992|-0.223|||||||
russ2000_2_0157|CNST|201709||||||||||||||||||||||||||||||||||1.1992||-12.1751||||||-8.1573|0||||||||1.981|-9.782|-9.782|-0.201|||||||
russ2000_2_0157|CNST|201712|17.722|16.404||1.121||11.708|11.131|0.577||-165.833|-173.912|||||||||||||||2.799|173.228|||||||1.1992||-14.1599|||27.0394|||-9.9503|0|||-35.377|||||1.835|-11.932|-11.932|-0.044|||||||
russ2000_2_0157|CNST|201803|73.391|71.502||1.017||10.328|10.049|0.279||64.728|-186.014|||||||||||||||3.472|0.002|||||||0.973||-12.44|||27.0394|||-12.44||||-41.808|||||2.303|-12.102|-12.102|0.075|||||||
russ2000_2_0157|CNST|201806|90.605|88.54||0.885||10.003|9.413|0.59||-188.215|-197.955||||-11.6104|||||||0||0.0944||2.679|272.834|||||||1.1992|64|-9.96|25.7188||27.0394|||-9.96||||-45.757|||||2.486|-11.941|-11.941|0.081|11.06|11.06|469.3489|76942.4333||10.41|
russ2000_2_0157|CNST|201809|132.012|128.475||0.825||10.699|10.521|0.178||122.563|-213.893||||-8.8556||||1.3002|||0||0.3809||4.309|0.003|||||||19.6192||-0.81|25.7844||25.7844|||-0.81|-55.801|||-51.913|||||3.68|-15.938|-15.938|0.475|6.73|6.73|357.9865|58925.7||6.18|5.9
russ2000_2_0157|CNST|201812|117.303|114.592||1.21||14.78|14.66|0.12||104.158|-233.837||||0.2256||||0.9934|||0||0.2311||5.723|0.003|||||||25.8031|82|-0.77|25.8031||25.8031|||-0.77|0|||-59.925|||||4.006|-19.944|-19.944|0.688|4.01|4.01|-11.1216|29498.8||7.23|10.1
russ2000_2_0157|CNST|201903|118.486|115.791||6.012||38.848|17.121|21.727||86.075|-253.263||||-4.7684||||3.3571|||0||3.4962||7.523|0.003|||||||25.8046||-0.75|25.807||25.807|||-0.75||||-67.249|||||4.429|-19.426|-19.426|0.68|13.55|13.55|235.0752|137909.6||13.15|8.62
russ2000_2_0157|CNST|201906|100.666|98.1||13.162||47.069|17.201|29.868||67.184|-274.03||||-3.9355||||3.6818|||0||4.3166||6.387|0.003|||4|4.8528|||25.8096||-0.8|25.8194||25.8194|||-0.8|0|||-76.075|||||4.886|-20.767|-20.767|0.074|12.28|12.28|220.6504|87006.6333|-16.3653|9.25|7.25
russ2000_2_0157|CNST|201909|92.21|89.066||12.521||57.065|17.754|39.311||48.152|-295.179||||-1.541||||3.4702|||0||2.7958||4.983|0.003|||3|5.0559|||25.8291||-0.82|25.8665||25.8665|||-0.82|-0.145|||-81.286|||||4.81|-21.149|-21.149|-0.098|6.46|6.46|107.6346|59072.1667|-4.0119|13.81|46.56
russ2000_2_0157|CNST|201912|386.989|383.934||11.716||61.546|22.755|38.791||337.584|-319.387||||-22.0858||||5.8219|||0||4.3366||7.278|0.004|||10|8.9008|||35.1633|106|-0.66|41.719||41.719|||-0.66|-306.882|||-85.55|||||5.471|-24.184|-24.208|-0.127|47.11|47.11|1611.0901|803369.6667|1074.813|33.04|35.34
russ2000_2_0157|CNST|202003|361.666|358.849||10.97||57.535|19.285|38.25||315.526|-344.831||||-12.2477||||4.166|||0||4.7704||3.558|0.004|||10|4.9921|||41.7656||-0.61|41.8221||41.8221|||-0.61||||-91.568|||||5.908|-25.429|-25.444|0.554|31.43|31.43|985.3006|385862.6667|131.9557|35.98|35.53
russ2000_2_0157|CNST|202006|523.099|520.513||10.821||62.817|27.284|35.533||471.981|-374.584||||-11.2136||||3.0242|||0||8.8232||5.659|0.005|||10|2.5387|||42.5894||-0.7|47.5||47.5|||-0.7005|-180.727|||-100.554|||||6.96|-29.729|-29.753|-0.171|30.05|30.05|936.581|852406|144.7068|26.89|21.05
russ2000_2_0157|CNST|202009|||||||||||||||-5.6459||||2.039|||0||10.4331||||||10|1.4579||||||||||||||||||||||||20.26|20.26|471.556|537845.4|213.6223|24.2|